ATE408686T1 - Chondrosarcom-assoziierte gene - Google Patents

Chondrosarcom-assoziierte gene

Info

Publication number
ATE408686T1
ATE408686T1 AT99909962T AT99909962T ATE408686T1 AT E408686 T1 ATE408686 T1 AT E408686T1 AT 99909962 T AT99909962 T AT 99909962T AT 99909962 T AT99909962 T AT 99909962T AT E408686 T1 ATE408686 T1 AT E408686T1
Authority
AT
Austria
Prior art keywords
chondrosarcoma
associated genes
gene
nucleic acid
methods
Prior art date
Application number
AT99909962T
Other languages
German (de)
English (en)
Inventor
Richard Terek
Original Assignee
Rhode Island Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhode Island Hospital filed Critical Rhode Island Hospital
Application granted granted Critical
Publication of ATE408686T1 publication Critical patent/ATE408686T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
AT99909962T 1998-03-13 1999-03-12 Chondrosarcom-assoziierte gene ATE408686T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/042,225 US6207812B1 (en) 1998-03-13 1998-03-13 Chondrosarcoma associated genes

Publications (1)

Publication Number Publication Date
ATE408686T1 true ATE408686T1 (de) 2008-10-15

Family

ID=21920744

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99909962T ATE408686T1 (de) 1998-03-13 1999-03-12 Chondrosarcom-assoziierte gene

Country Status (11)

Country Link
US (2) US6207812B1 (https=)
EP (1) EP1062333B1 (https=)
JP (1) JP2002506617A (https=)
AT (1) ATE408686T1 (https=)
AU (1) AU762987B2 (https=)
CA (1) CA2323076A1 (https=)
DE (1) DE69939583D1 (https=)
DK (1) DK1062333T3 (https=)
ES (1) ES2317690T3 (https=)
PT (1) PT1062333E (https=)
WO (1) WO1999046382A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
KR102181548B1 (ko) * 2019-02-20 2020-11-20 한국외국어대학교 연구산학협력단 염증성 질환 또는 자가면역성 질환의 예방 또는 치료 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US5175385A (en) 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5350835A (en) * 1991-11-05 1994-09-27 Board Of Regents, University Of Texas Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
US5744343A (en) * 1994-01-04 1998-04-28 Mitotix, Inc. Ubiquitin conjugating enzymes
US5612455A (en) * 1994-07-05 1997-03-18 Tularik, Inc. Nuclear factors and binding assay

Also Published As

Publication number Publication date
US6207812B1 (en) 2001-03-27
JP2002506617A (ja) 2002-03-05
AU762987B2 (en) 2003-07-10
DE69939583D1 (de) 2008-10-30
WO1999046382A1 (en) 1999-09-16
US20010016649A1 (en) 2001-08-23
AU2904099A (en) 1999-09-27
US7211646B2 (en) 2007-05-01
DK1062333T3 (da) 2009-01-26
ES2317690T3 (es) 2009-04-16
PT1062333E (pt) 2008-12-24
CA2323076A1 (en) 1999-09-16
EP1062333B1 (en) 2008-09-17
EP1062333A1 (en) 2000-12-27

Similar Documents

Publication Publication Date Title
IT1314250B1 (it) Proteine (iip) che interagiscono con il recettore igf-1 geni che lecodificano e loro impiego.
DE60030145D1 (de) Nachweisverfahren für kurze sequenzvarianten
DE60042556D1 (de) Für polyepitop-polypeptide kodierende nukleinsäuren
DE69634412D1 (de) Regulierte gene und ihre verwendungen
DE69736068D1 (de) Faktor viii vom schwein und hybriden
DE60109430D1 (de) An entzündlichen darmerkrankungen beteiligte gene und deren verwendung
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
ATE316577T1 (de) Das goodpasture-antigen bindende protein
BR9710919A (pt) Proteina purificada sr-p70
ATE202570T1 (de) Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen
DE69939583D1 (de) Chondrosarcom-assoziierte gene
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
WO2000021986A3 (en) Matrix-remodeling genes
NZ518458A (en) Isolate DNA polymerase lambda and uses thereof
DK0923644T3 (da) G-koblet receptor, der udviser selektiv selektivitet for ATP
EP0970192A4 (en) NUCLEIC ACID CODING THE ALGU PROTEIN OF M. TUBERCULOSIS.
DK1129191T3 (da) Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme
PE20399A1 (es) Muteina ob
DE60226244D1 (de) Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind
ATE319826T1 (de) Minimale promotoren und ihre verwendung
DE69832447D1 (de) Gen kodierend für Afadin-1
DE60040668D1 (de) Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
WO2003060074A3 (en) Novel metastasis suppressor gene on human chromosome 8

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1062333

Country of ref document: EP

REN Ceased due to non-payment of the annual fee